enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dapagliflozin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin

   Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment

3. Dapagliflozin/saxagliptin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin/saxagliptin

   In the European Union, it is indicated in adults aged 18 years and older with type 2 diabetes: to improve glycemic control when metformin with or without sulphonylurea (SU) and either saxagliptin or dapagliflozin does not provide adequate glycemic control. [3] when already being treated with saxagliptin and dapagliflozin. [3]

4. 4 Ways to Prevent Muscle Loss on Ozempic & Other Weight ... - AOL

   www.aol.com/4-ways-prevent-muscle-loss-115800184...

   For instance, a 2013 trial assessed the effect of protein intake for 39 adults on a reduced-calorie diet. It found that those who doubled the daily recommended intake (1.6 g/kg of body weight ...

5. Obesity dipped in U.S. adults last year for the first time in ...

   www.aol.com/obesity-dipped-u-adults-last...

   Obesity dipped slightly in U.S. adults last year for the first time in more than a decade, a study found. The researchers suggested that might be due, in part, to the rise of weight loss drugs ...

6. New Phase III Data Showed Dapagliflozin Significantly ... - AOL

   www.aol.com/2013/09/24/new-phase-iii-data-showed...

   For premium support please call: 800-290-4726 more ways to reach us

7. Dapagliflozin/sitagliptin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin/sitagliptin

   It contains dapagliflozin, as propanediol monohydrate, a SGLT-2 inhibitor; and sitagliptin, as phosphate monohydrate, a DPP-4 inhibitor. [1] It is taken by mouth. [1]

8. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors ...

9. AstraZeneca's Dapagliflozin No Longer Authorized For Type 1 ...

   www.aol.com/news/astrazenecas-dapagliflozin-no...

   The SGLT2 inhibitor dapagliflozin has been indicated for the treatment of type 2 diabetes since 2012. AstraZeneca Plc's (NASDAQ: AZN) dapagliflozin 5mg (Forxiga/Farxiga) was authorized in 2019 as ...